Order
338990-31-1
(2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate
132249-12-8
2-(2-AMINO-4-BIPHENYL)PROPIONITRILE
677-24-7
METHYL PHOSPHORODICHLORIDATE
67701-29-5
ANTIFOAM B
67701-20-6
SODIUM DILINOLEATE
677010-34-3
Motavizumab
132244-31-6
5-BROMO-BENZOOXAZOLE
214902-82-6
Decladinose Roxithromycin (Roxithromycin Impurity B)
827-44-1
5-CHLORO-3-PHENYL-1,2,4-OXADIAZOLE
67701-03-5
FATTY ACIDS C16-18
62732-44-9
CBI-BB ZERO/005050
21487-48-9
3-METHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE, 97%
660425-16-1
2-Bromo-3,5-Fluoropyridine
67700-92-9
Fatty acids, tall-oil, polymers with pentaerythritol and phthalic anhydride
67701-23-9
Talloilacid,magnesium salt
67700-82-7
Linseed oil, polymer with pentaerythritol, phthalic anhydride and soybean oil
82747-36-2
6,7-DIHYDROXY-4-(TRIFLUOROMETHYL)COUMARIN
62728-88-5
RHODIUM(II) TRIMETHYLACETATE
67706-68-7
TERT-BUTYL 3-(ETHOXYCARBONYL)-2-OXOPROPYLCARBAMATE
67703-99-5
Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine and 1,2-dichloroethane
13224-40-3
p-Tetradecyloxyphenol
677010-34-3, CAS No. 677010-34-3,CasNo 677010-34-3,cas 677010-34-3
Motavizumab